Author Topic: CPC ประจำเดือน ตุลาคม 2554 อ.รังสรรค์ ฤกษ์นิมิตร  (Read 11172 times)

0 Members and 4 Guests are viewing this topic.

nattapun

  • เด็กล้างจาน
  • *
  • Posts: 28
    • Email
CPC ประจำเดือน ตุลาคม 2554

วันพฤหัสบดีที่ 20 ตุลาคม 2554 เวลา 12.00-13.00 น. ห้องประชุมชั้น 1 ตึกอบรมวิชาการ

ผู้อภิปรายหลัก
Clinician: นพ.รังสรรค์ ฤกษ์นิมิตร์
Radiologist: พญ.ณัฐพร ตั่นเผ่าพงษ์
Diagnostician: to be announced (concealed identity)
ขอเชิญอาจารย์ แพทย์ประจำบ้าน แพทย์ประจำบ้านต่อยอด extern นิสิตแพทย์ และผู้สนใจ เข้าร่วมอภิปรายครับ


ณัฐพันธ์ R3
« Last Edit: September 27, 2011, 09:24:00 PM by Wanla »

chusana

  • เด็กเสิร์ฟ
  • ***
  • Posts: 243
Dear all students, residents, fellows, staffs, and others:
This fascinating CPC case is a 47-year-old man who presented with chronic intermittent 30-year course of UGI bleeding likely due to a complication of portal hypertension; in accompanying with multiple polyps from hypopharynx, esophagus, stomach, entire small and large bowels; multiple subcutaneous nodules; hyperpigmented macules at glans penis; multiple hypodense lesions at the liver, spleen, and bone; and significant familial history of HCC in his father and multiple subcutaneous nodules in his mother and daughter.
Every one is very much welcome to open the discussion and to make comments na krab!
Chusana
« Last Edit: September 27, 2011, 09:24:17 PM by Wanla »

KGB

  • หัวหน้าบ๋อย
  • ****
  • Posts: 270
    • Clinical genetics

KGB

  • หัวหน้าบ๋อย
  • ****
  • Posts: 270
    • Clinical genetics
How's pity that there is no one interested in genetics. :(
Ok I will give the comments here to open the discussion.

This man has multiple polyps through the GI tracts and presented with multiple epsiodes of GI bleeding. But he also has portal hypertension that might be the culprit of GI hemorrhage too.

It is quite difficult to differential GI polyps without knowledge of pathology of the polyps that can be adenomatous, harmatomatous or juvenile or hyperplastic polyps that are the component of different syndromes.

But this patient has other manifestations that leads to the final diagnosis that is the multiple subcutaneous nodules, hyperpigment of glans penis and vascular malformations of the liver.

Cowden, Proteus and Bannayan Ruvalcalba-Riley syndrome are the syndrome that can present like these. They are all caused by the mutations in the same genes but it is the somatic mutation in Proteus syndrome and germ line mutation in Cowden and BRR syndrome. CD and BRR are sometimes happened in the same patients. The clinical that will use to diagnosis of Cowden is the skin manifestation : trichilemmoma. BRR can have macrocephaly, glans penis or penile shaft hyperpigmentation and learning disability problem. CD and BRR is inherited as autosomal dominant fashion. Proteus is somatic mutation and present with hemihypertrophy with various vascular malfomation.

Adenomatous polyposis usually confine in large intestine and once found throughout the bowel, there are some malignant lesions between them.

Juvenile polyps in Peuts Jegher syndrome can be found in small intestine, stomach. And patients sometimes have perioral hyperpigmentation.

chusana

  • เด็กเสิร์ฟ
  • ***
  • Posts: 243
Dear Aj KGB:
But why this patient had portal hypertension ???
And if the inheritance is autosomal dominant fashion, must all members be taken examination?
And is there incomplete penetrance in these genetic syndrome?
Chusana

KGB

  • หัวหน้าบ๋อย
  • ****
  • Posts: 270
    • Clinical genetics
Hemangioma or other hepatic vascular malformations can cause secondary portal hypertension.

Of course, as this is the autosomal dominant disease with protean clinical manifestations, all the children who have 50 % risks to develop the syndrome (and may be his siblings if his mom is also suggested to be the case) should be investigated and close followed up with the physicians familiar with this syndrome. Breast cancer and thyroid cancer screenings and dermatological, GI, and behavioral problems should be examined. Gene mutations if known can be used to test the offsprings at high risk to exclude non mutation carriers from unnecessary aggressive surveillance and clinical follow up.
The tests in children should be discussed with geneticists to establish the appropriate time for diagnosis when it will benefit to the children themself, not for the parental concerns or doctor interests.

After finding that germ line PTENs gene mutations are responsible for both typical Cowden syndrome and Bannayan-Ruvalcalba-Rielley syndrome, there is the suggestion that we should group these patients into the big baskets 'PTENs harmatomatous tumour syndrome' and we have seen patients with typical CDS and BRR in the same family with the same underlied gene mutation. SO there is variable expression and incomplete penetrance (age-dependent penetrance and clinical penetrance) which is the general characteristics of autosomal dominant disease. (We don't normally use the terms 'incomplete penetrance' or 'variable expression' for autosomal recessive diseases)


KGB

  • หัวหน้าบ๋อย
  • ****
  • Posts: 270
    • Clinical genetics
As 5-10% of all cancer patients are strongly genetic determined, cancer genetic service would be set up in a next few years to provide the genetic tests, genetic counseling for cancer patients and people with high familial risk for developing cancer. Coordinating with multidisciplinary teams including oncologists, Gastro-eneterologists, surgeons, diagnostic radiologists, gynecologists, radiotherapists, psychiatrists, geneticists, we can offer the medical and psychological support, surveillance, chemoprevention and prophylactic interventions for these group of patients and relatives with high risk. Treatment specific to each gene mutation carriers are also ongoing developed and promising to be benefit for specific group of patients.

Primary care physicians and non-genetic specialists should keep in mind that familial history is the simplest tool to unravel these not-uncommon inherited cancer syndromes. Take less than 2 minutes to screen the familial history for your patients!!!

chusana

  • เด็กเสิร์ฟ
  • ***
  • Posts: 243
Dear Aj KGB:
Many tons of thanks ;)
But can you explain PTEN gene? What is it? How can its mutation cause several kinds of unique syndrome ???
Chusana

KGB

  • หัวหน้าบ๋อย
  • ****
  • Posts: 270
    • Clinical genetics
PTEN gene is a gene producing a ubiquitously expressed protein with phosphatase activity, that give the name to the gene (phosphatase and tensin homolog). It negatively regulates the AKT and mTOR (mammalian target of rapamycin) pathways that involve with multiple cellular pathway including cell proliferation, and angiogenesis.
Due to its ubiquitously expression profiles and multiple cellular activities, it is not surprising that the mutation of this gene can cause variety of phenotype both malignancy and non malignant phenotypes dominate by overgrowth and vascular malformations krub.

chusana

  • เด็กเสิร์ฟ
  • ***
  • Posts: 243